A Randomised Trial Investigating the Effect on Biochemical (PSA) Control and Survival of Different Durations of Adjuvant Androgen Deprivation in Association With Definitive Radiation Treatment for Localised Carcinoma of the Prostate.

Trial Profile

A Randomised Trial Investigating the Effect on Biochemical (PSA) Control and Survival of Different Durations of Adjuvant Androgen Deprivation in Association With Definitive Radiation Treatment for Localised Carcinoma of the Prostate.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Zoledronic acid (Primary) ; Leuprorelin
  • Indications Bone metastases; Fracture; Osteoporosis; Prostate cancer
  • Focus Adverse reactions; Registrational
  • Acronyms RADAR
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2014 Planned primary completion date changed to 1 Aug 2017.
    • 03 Jun 2014 Interim Results at median 7.4 year presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top